| Teva Pharma AG - Bicalutamid-Teva 150 mg, Filmtabletten | | 58427 | | 02 | | Bicalutamid-Teva 150 mg | | Filmtabletten | | L02BB03 | | Bicalutamid | | 14.05.2009 | | |
| | Composition | | bicalutamidum 150 mg, cellulosum microcristallinum, povidonum K 30, carmellosum natricum conexum, natrii laurilsulfas, lactosum monohydricum 105 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, polydextrosum, E 171, macrogolum 4000, pro compresso obducto corresp. natrium 9.582 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Bicalutamide | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Bicalutamide | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 105 mg | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Polydextrosum | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
